Exploring the perception of key stakeholders toward khat policy approaches in Ethiopia: a qualitative study.

Ethiopia Khat harm reduction Khat use Khat use disorder Perception Policy approaches Qualitative study

Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
26 08 2023
Historique:
received: 29 10 2022
accepted: 23 08 2023
medline: 28 8 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Khat is an amphetamine-like plant, produced and commonly chewed in Ethiopia by a large group of the population. Although significant multidimensional harms of khat use have been reported, currently, there are no policies or organized activities against khat use in Ethiopia. Therefore, the current study aimed to explore the perception of key stakeholders toward khat policy approaches for Ethiopia. A qualitative study was conducted using focus group discussion (FGD) and in-depth interview (IDI). Ten stakeholders participated in the IDIs, and another 15 individuals participated in the FGDs. Key stakeholders were appropriately mapped and purposively selected based on their experience related to khat use and khat harm reduction. Interviews and FGDs were led by the study authors and were audio-recorded. The audio-recorded data were transcribed verbatim and then translated into English language. The data were analyzed using thematic analysis approach. Participants preferred prevention and law regulation measures for khat policy approaches for Ethiopia. Proposed prevention and law regulation measures included regulating the transportation of khat, limiting the minimum age to buy and sell khat, prohibiting khat use at some public places, banning khat advertising and promotion, and imposing excise tax. Individual level khat harm reduction strategies were also proposed to be useful. However, the participants asserted that total khat ban in Ethiopia is not likely to be feasible and acceptable. Prevention, treatment or care for individuals with problematic khat use, law regulation, and harm reduction were preferred approaches by stakeholders for khat policy in Ethiopia instead of total banning.

Sections du résumé

BACKGROUND
Khat is an amphetamine-like plant, produced and commonly chewed in Ethiopia by a large group of the population. Although significant multidimensional harms of khat use have been reported, currently, there are no policies or organized activities against khat use in Ethiopia. Therefore, the current study aimed to explore the perception of key stakeholders toward khat policy approaches for Ethiopia.
METHODS
A qualitative study was conducted using focus group discussion (FGD) and in-depth interview (IDI). Ten stakeholders participated in the IDIs, and another 15 individuals participated in the FGDs. Key stakeholders were appropriately mapped and purposively selected based on their experience related to khat use and khat harm reduction. Interviews and FGDs were led by the study authors and were audio-recorded. The audio-recorded data were transcribed verbatim and then translated into English language. The data were analyzed using thematic analysis approach.
RESULTS
Participants preferred prevention and law regulation measures for khat policy approaches for Ethiopia. Proposed prevention and law regulation measures included regulating the transportation of khat, limiting the minimum age to buy and sell khat, prohibiting khat use at some public places, banning khat advertising and promotion, and imposing excise tax. Individual level khat harm reduction strategies were also proposed to be useful. However, the participants asserted that total khat ban in Ethiopia is not likely to be feasible and acceptable.
CONCLUSION
Prevention, treatment or care for individuals with problematic khat use, law regulation, and harm reduction were preferred approaches by stakeholders for khat policy in Ethiopia instead of total banning.

Identifiants

pubmed: 37633925
doi: 10.1186/s12954-023-00858-y
pii: 10.1186/s12954-023-00858-y
pmc: PMC10463779
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

PLoS One. 2019 Nov 5;14(11):e0224606
pubmed: 31689323
Reprod Health. 2015 Aug 29;12:78
pubmed: 26319026
BMJ Open. 2020 Oct 12;10(10):e037907
pubmed: 33046468
Am J Public Health. 2005 Jun;95(6):936-8
pubmed: 15914812
Acta Psychiatr Scand Suppl. 1999;397:84-91
pubmed: 10470360
Integr Blood Press Control. 2019 Dec 20;12:33-42
pubmed: 31908523
J Neurosci Rural Pract. 2017 Jan-Mar;8(1):30-37
pubmed: 28149078
Ann Gen Psychiatry. 2020 Mar 09;19:16
pubmed: 32165908
Open Cardiovasc Med J. 2017 Dec 19;11:146-155
pubmed: 29387278
J Clin Exp Dent. 2017 Oct 01;9(10):e1264-e1270
pubmed: 29167719
Addiction. 2010 Oct;105(10):1688-95
pubmed: 20039859
Addiction. 2007 May;102(5):684-90
pubmed: 17506148
Biomed Res Int. 2015;2015:313692
pubmed: 26273606
Int J Drug Policy. 2009 Nov;20(6):509-13
pubmed: 19535239
Eur Addict Res. 2019;25(4):161-172
pubmed: 30991392
Drug Alcohol Depend. 2009 Jun 1;102(1-3):1-10
pubmed: 19332365
Afr Health Sci. 2016 Sep;16(3):822-830
pubmed: 27917217
Saudi Med J. 2002 Jul;23(7):850-3
pubmed: 12174239
PLoS One. 2018 Apr 12;13(4):e0195718
pubmed: 29649253
Mayo Clin Proc. 2010 Nov;85(11):974-80
pubmed: 20926835
BMC Public Health. 2018 Aug 15;18(Suppl 1):954
pubmed: 30168395
BMC Public Health. 2014 Nov 21;14:1198
pubmed: 25416647
Subst Abuse Treat Prev Policy. 2017 Nov 2;12(1):47
pubmed: 29096691
J Subst Abuse Treat. 1988;5(3):163-9
pubmed: 3070051
Psychiatry J. 2020 Jan 06;2020:1462141
pubmed: 31970194
Gen Pharmacol. 1984;15(3):179-87
pubmed: 6376274
BMC Public Health. 2013 Jul 30;13:693
pubmed: 23895376
PLoS One. 2015 Jun 19;10(6):e0130460
pubmed: 26090658
Addiction. 2016 Sep;111(9):1666-76
pubmed: 27061394
Prev Sci. 2020 Jan;21(1):65-85
pubmed: 31641922
Subst Use Misuse. 2008;43(6):784-802
pubmed: 18473222
Am J Public Health. 2004 Jun;94(6):1027-9
pubmed: 15249310
J Periodontal Res. 2017 Dec;52(6):937-945
pubmed: 28626895
J Ethnopharmacol. 2010 Dec 1;132(3):607-14
pubmed: 20227478

Auteurs

Kassahun Habtamu (K)

School of Psychology, College of Education and Behavioral Studies, Addis Ababa University, Addis Ababa, Ethiopia.

Solomon Teferra (S)

Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia.

Awoke Mihretu (A)

Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia. awoke.mihretu@aau.edu.et.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH